Science ❯ Biotechnology

Pharmaceutical Research

Clinical Trials Bacterial Vaccine Cancer Treatments Production Facilities Cancer Research Oncology Drug Discovery Protein Therapeutics Targeted Therapies Cancer Drug Development

Roche Rolls Out NVIDIA-Powered AI Factory, Adding 2,176 Blackwell GPUs to Top 3,500-Chip Footprint

Roche casts the buildout as the next phase of its 2023 NVIDIA collaboration to embed AI across its value chain.

KALA BIO Says First AI Agent Ships in Two Weeks as Shares Soar Pre-Market

FDA Demands Placebo-Controlled Trial for UniQure’s Huntington’s Gene Therapy

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

Takeda Strikes Multi-Year AI Drug Discovery Pact With Iambic Worth Over $1.7 Billion

Lilly and Nimbus Strike Multi-Year AI Deal for Oral Obesity Drugs

Cosmo’s Clascoterone Meets Phase III Goals in Male-Pattern Baldness Trials

Llama and Alpaca Nanobody Antivenom Neutralizes 17 African Elapid Venoms in Mice

Merck Breaks Ground on $3 Billion Virginia Plant in $70 Billion U.S. Expansion

Lilly Launches TuneLab, Opening Proprietary AI Drug-Discovery Models to Startups

Bath Researchers Advance Pill-Based Protein Therapy Toward Human Trials

Isomorphic Labs Nears First Human Trials of AI-Designed Drugs

BioNTech and Pfizer Agree to $1.2 Billion Settlement Over U.S. Vaccine Patent Disputes

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline